During the past decade, Tulane Hemophilia Treatment Ctr. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tulane Hemophilia Treatment Ctr." #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Glaxo Wellcome" with 2 trials as a collaborator, "American Thrombosis and Hemostasis Network" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Bioverativ Therapeutics Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Tulane Hemophilia Treatment Ctr." are "HIV Infections" (6 trials), "Hemophilia A With Inhibitor" (2 trials), "Hemophilia B With Inhibitor" (2 trials), "Haemophilia A Without Inhibitor" (1 trials) and "Haemophilia B Without Inhibitor" (1 trials). Many other conditions were trialed in "Tulane Hemophilia Treatment Ctr." in a lesser frequency.

Most popular intervention types in "Tulane Hemophilia Treatment Ctr." are "Drug" (9 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (5 trials), "Didanosine" (4 trials), "Lamivudine" (3 trials), "Stavudine" (3 trials) and "Zalcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tulane Hemophilia Treatment Ctr." are 12 trials for "All" genders.

Currently, there are NaN active trials in "Tulane Hemophilia Treatment Ctr.". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Tulane Hemophilia Treatment Ctr., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Tulane Hemophilia Treatment Ctr., 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".